Flagship Labs 83, Inc. – Trademark Portfolio

Entity Type: 03

Flagship Labs 83, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 3 are pending. The owner is based in Cambridge, MA.

Building 600/700, Suite 7-201

One Kendall Square

Cambridge, MA 02139

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Flagship Labs 83, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

40
Treatment & Processing (3 filings)

Treatment of materials

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Flagship Labs 83, Inc. have?

Flagship Labs 83, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 pending, 2 abandoned.

What trademark classes does Flagship Labs 83, Inc. file in?

Flagship Labs 83, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Flagship Labs 83, Inc.'s trademark registration success rate?

Flagship Labs 83, Inc. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.